QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

9.09B

Market cap9.09B

Price-Earnings ratio

22.81

Price-Earnings ratio22.81

Dividend yield

0.78%

Dividend yield0.78%

Average volume

3.60M

Average volume3.60M

High today

$44.75

High today$44.75

Low today

$43.78

Low today$43.78

Open price

$44.39

Open price$44.39

Volume

3.29M

Volume3.29M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $44.07. The company's market cap stands at 9.09B, with a P/E ratio of 22.81 and a dividend yield of 0.78%.

During the trading session on 2026-08-22, QIAGEN(QGEN) shares reached a daily high of $44.75 and a low of $43.78. At a current price of $44.07, the stock is +0.7% higher than the low and still -1.5% under the high.

Trading activity shows a volume of 3.29M, compared to an average daily volume of 3.6M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 8h

Wellington Discloses 5.1% Voting Stake in Qiagen via AFM Filing

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Nasdaq 15h

Qiagen Reaches Analyst Target Price

In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $55.01, changing hands for $56.47/share. W...

TipRanks 3d

BlackRock Revealed as Major Qiagen Shareholder in AFM Filing

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

55%

of 22 ratings

Buy

45.5%

Hold

54.5%

Sell

More QGEN News

Simply Wall St 6d

Should FDA Clearance Of QIAstat-Dx Sepsis Panel Require Action From Qiagen Investors?

In August 2026, QIAGEN received U.S. FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, expanding its QIAstat-Dx platform into bloodstream infection diag...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.